Back

The association between SGLT2 inhibitors and new-onset arrhythmias: A nationwide population-based longitudinal cohort study

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Risk Factors and Prevention ePosters Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Wun-Zhih Siao

Taichung (Taiwan)

217 More presentations in this session

Presentation thumbnail
The association between napping and the risk of cardiovascular disease and all-cause mortality: a systematic review and dose-response meta-analysis
Doctor Z. Pan (Guangzhou, CN)
Abstract Slides
Presentation thumbnail
Prediction of 10-year and lifetime risk of cancer in individual patients with established cardiovascular disease, results from UCC-SMART and CANTOS
Miss C. van 't Klooster (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Geographical profiles of cardiovascular risk and the risk factors in China: data from a nationwide population-based screening project
Assistant Professor C. Wu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Associations between life-course frailty and later-life heart size and function in the 1946 NSHD British birth cohort-an epidemiological study
Mr C. Topriceanu (London, GB)
Abstract Slides
Presentation thumbnail
Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions
Doctor P. Welsh (Glasgow, GB)
Abstract Slides

Access the full session

Session thumbnail
Risk Factors and Prevention ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular benefits of SGLT2i in type 2 diabetes without heart failure: a subgroup analysis
30 August 2025
thumbnail
Congress Session
Insights into arrhythmia mechanisms
26 August 2022
thumbnail
Congress Presentation
Divergent electrophysiologic safety profile of dapagliflozin and empagliflozin in a whole-heart model
27 August 2022
thumbnail
Congress Presentation
Association of diabetes mellitus status and clinical outcomes of edoxaban in patients with atrial fibrillation: a sub-analysis from the ETNA-AF Asian registry
12 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources